United Kingdom
|
Saturday, 22 November 2008
|
|
|
| View All Articles About 'Vaccine' |
|
| 1. |
Doctor chooses Gardasil over Cervarix
Even though the government chose Glaxo's Cervarix for its cervical cancer vaccine programme, many British doctors pick Merck's Gardasil for their own daughters, a well-known physician said on Friday.
24 Oct 2008 |
| 2. |
Study clears measles vaccine of autism link
Scientists who tried to replicate a study that once tied a measles vaccine with autism said on Wednesday they could not find any link and hope their study will encourage parents to vaccinate their children to combat a rash of measles outbreaks.
04 Sep 2008 |
| 3. |
New-style bird flu vaccine shows promise
A new-style bird flu vaccine made using monkey cells instead of chicken eggs appears to be safe and effective, corporate researchers reported on Wednesday.
12 Jun 2008 |
| 5. |
Students take up HPV vaccine
Up to 70 percent of British schoolgirls are likely to take up the offer of a vaccine to protect them against cervical cancer, despite doubts about other vaccines, researchers reported on Thursday.
25 Apr 2008 |
| 6. |
Infant study casts doubt on vaccine-autism link
The mercury in a vaccine preservative is pumped out of a baby's body too quickly for it to do any damage, researchers reported on Wednesday in a study they say should further absolve shots of causing autism.
31 Jan 2008 |
| 8. |
Glaxo bird flu vaccine works in trial
A bird flu vaccine for humans, which requires only a very low dose of active ingredient, has proved effective in clinical tests, its maker GlaxoSmithKline said on Wednesday.
26 Jul 2006 |
| 9. |
Glaxo to Create Bird Flu Vaccines
Pharmaceutical company GlaxoSmithKline PLC said Thursday it has begun international clinical trials of two pandemic vaccines against the H5N1 strain of bird flu in humans.
30 Mar 2006 |
| 10. |
Chiron Recalls Vaccine in Developing Areas
Biotech company Chiron Corp. said Thursday it was recalling and withdrawing a measles, mumps and rubella vaccine that it supplies to developing countries and to Italy because of a higher rate of adverse effects after immunization versus other similar vaccines.
16 Mar 2006 |
|
[1] |
|
|
|
|
|
|